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Abstract To analyze mechanisms of senescence-associated gene
expression, we have investigated histone deacetylases (HDACs)
in human fibroblasts undergoing replicative senescence. We
found that the overall acetylation pattern of histones does not
vary detectably with replicative senescence. By Northern blot and
Western blot, we found a significant decrease in the abundance of
HDAC-1 in senescent cells. Biochemical analysis of deacetylase
activities in extracts from old and young cells revealed a striking
difference. While by anion exchange chromatography we found a
single peak of activity in extracts from young cells, which
coincided with the elution of both HDAC-1 and HDAC-2, in
senescent cells a second peak of activity was found. This second
peak of activity is associated with HDAC-2 but does not contain
HDAC-1. These results suggest that HDAC-2 is present in at
least two distinct forms, one of which is specific for senescent
cells. Further biochemical characterization of the enzyme activity
revealed that addition of nicotinamide adenine dinucleotide
(NAD) did not detectably influence the activity of any fraction,
suggesting that NAD is not an essential co-factor for the
analyzed HDACs from diploid human fibroblasts. ß 2001 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
Replicative senescence of diploid human ¢broblasts has
been proposed as an experimental model for human ageing
(for recent review, see [1]). Cellular ageing is associated with
drastic changes in gene expression. On the one hand, a set of
genes is downregulated in senescent cells ([2,3] ; for review, see
[4]). This concerns mainly growth-associated and cell cycle
regulatory genes. On the other hand, it was also shown that
a group of genes consisting of quite divergent members is
upregulated as diploid ¢broblasts approach the senescent
state. These are referred to as senescence-associated (SA)
genes and include the amyloid precursor protein [5], insulin-
like growth factor binding protein-3 [6], cyclins D1 and E
[7,8], the cdk inhibitors p16INK4a [9,10] and p21WAF-1/
Cip1 [11,12] as well as a few other genes ([13], for review,
see [14]). While the SA downregulation of growth-regulated
proteins can be explained in part by the irreversible cell cycle
arrest that pertains in senescent ¢broblasts [15], transcription-
al upregulation of SA genes is less clear as far as the mecha-
nisms are concerned. In some cases, for example for the genes
encoding the cdk inhibitor p16INK4a [16] and the p53-inter-
acting protein p14ARF [17,18], which are colocalized in the
INK4 locus (for review, see [19]), a senescence-dependent loss
of active repression has been discussed [20]. Upregulation of
both the p14 and p16 genes correlates with the loss of bmi1, a
transcriptional repressor of the Polycomb group of proteins
(for review, see [21]), as evidenced by genetic studies. How-
ever, the molecular mechanisms of SA gene regulation remain
largely unresolved.
It is known that the transcription of genes in vivo is con-
trolled to some extent by enzymes that modify the chromatin
structure, such as histone acetyltransferases and histone de-
acetylases (HDACs; for review, see [22]). In particular, a
prominent role for HDACs has been reported and it was
shown that transcriptional repression by HDACs plays a
role in growth arrest exerted by the retinoblastoma protein
(pRb) [23^25] and other cellular transcriptional repressors
[26]. In most instances, HDAC-1 and HDAC-2 are tightly
associated with each other in a ‘corepressor core complex’
that invariably contains also two other closely related pro-
teins, RbAp46 [27] and RbAp48 [28]. The ‘corepressor core
complex’ is a constitutive component of two distinct chroma-
tin-associated transcriptional repressor complexes, referred to
as the Sin3 [29] and NURD [30] complexes, respectively. It is
believed that these complexes play an essential role in tran-
scriptional repression (for review, see [31]). In senescent ¢bro-
blasts, pRb is present in the hypophosphorylated form, which
acts as a transcriptional repressor [32]. While it was reported
by others that inhibitors of HDAC, such as butyrate or tri-
chostatin A, can induce premature senescence in human ¢bro-
blasts [33] and modulate the lifespan of yeast cells [34], the
role of HDACs in senescence-speci¢c gene expression requires
further investigation.
In this communication, we have compared the activity and
expression levels of human HDACs in diploid ¢broblasts
undergoing senescence. The expression of HDAC-1 decreases
with increasing passage number of senescent cells, whereas
expression of HDAC-2 is only slightly reduced. When the
enzymatic activities of HDACs in old and young cells were
compared, we found that they di¡ered signi¢cantly in their
chromatographic behavior. In both cell types, a similar peak
of activity could be identi¢ed which coincides with the distri-
bution of the HDAC-1 protein. For HDAC-2, we found a
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completely di¡erent chromatographic behavior in senescent as
compared to young cells. While HDAC-2 from young cells
elutes as a single peak, HDAC-2 from senescent cells elutes
in several di¡erent forms, at least one of which is speci¢c for
senescent cells. We conclude that the abundance and activity
of HDACs is changing signi¢cantly with cellular senescence
and present direct biochemical evidence for a senescence-spe-
ci¢c HDAC activity.
2. Materials and methods
2.1. Cell culture
Normal diploid ¢broblasts were isolated from human foreskin [35]
and cultured in Dulbecco’s modi¢ed Eagle’s medium (Gibco Life
Technologies, Vienna, Austria), supplemented with penicillin/strepto-
mycin solution (Gibco Life Technologies, Vienna, Austria) and 10%
fetal calf serum (PAA, Linz, Austria). The cells were subcultured in an
atmosphere of 5% CO2 at 37‡C by passaging them at a ratio of 1:5 in
regular intervals. At later passages, the splitting ratio was reduced to
1:3 and 1:2, respectively. Cells were passaged such that the mono-
layers never exceeded 80% con£uency. Population doublings (PDL)
were estimated using the following equation: n = (log10F3log10I)/0301
(with n = PDL, F = number of cells at the end of one passage, I = num-
ber of cells that were seeded at the beginning of one passage). After
roughly 55 PDL, the cells reached growth arrest. The senescent status
was veri¢ed by in situ staining for SA-L-galactosidase as described
[36]. 90^100% of the cells at 55 PDL stained positive for SA-L-galac-
tosidase.
2.2. RNA extraction and Northern blot analysis
Total RNA was isolated using the ‘RNeasy kit’ (Qiagen, Hilden,
Germany), following the instructions of the manufacturer. 10^15 Wg
of RNA was separated by electrophoresis on gels containing 1.2%
agarose, 2.3% formaldehyde, 20 mM 3-N-morpholino-propanesul-
fonic acid, 5 mM Na-acetate, 1 mM EDTA, and transferred onto
positively charged nylon membranes (Hybond-N, Amersham Life
Science, Braunschweig, Germany) by capillary blotting. Membranes
were dried and the RNA was ¢xed by UV-crosslinking, using a Stra-
tagene Crosslinker. Prehybridization was performed for 1 h in ‘Quick
Hyb solution’ (Stratagene, Heidelberg, Germany) at 65‡C, then the
membranes were hybridized with 32P-labelled cDNA probes, gener-
ated by random primed labelling, in fresh solution for 1 h at 65‡C.
The membranes were washed twice in 2USSC/0.1% sodium dodecyl
sulfate (SDS) at room temperature for 15 min and once in 0.5USSC/
0.1% SDS at 65‡C and exposed to Kodak X-ray ¢lms with intensify-
ing screens at 370‡C. We used the plasmid constructs pcDNA3-
HDAC-1 and pcDNA3-HDAC-2 [37] to generate cDNAs for North-
ern blot hybridization.
2.3. Preparation of cellular extracts
To prepare whole cell extracts, cells were trypsinized from culture
£asks, washed with phosphate-bu¡ered saline (PBS) and lysed for 30
min on ice in a high stringency bu¡er (50 mM Tris^HCl, pH 7.5, 150
mM NaCl, 1% NP-40, 0.1% SDS, 0.5% Na-deoxycholate, 0.2 mM
phenylmethylsulfonyl-£uoride, 1 mM NaF, 10 Wg/ml aprotinin, 10
Wg/ml leupeptin). After centrifugation at 20 000Ug for 15 min at
4‡C, the supernatants were separated on SDS^polyacrylamide gels,
followed by immunoblotting, as described below. Since the total level
of protein per cell increases about 2.5-fold with replicative senescence
(M. Wagner et al., unpublished), due to an increased size of the
senescent cells [38], the loading of the gels was normalized to cell
number.
2.4. Preparation of nuclear extracts
Young (20 PDL) and senescent (56 PDL) ¢broblasts (equal number
of cells) were trypsinized from cell culture dishes, pelleted by centri-
fugation and washed in PBS. The cell pellets were resuspended in two
volumes of hypotonic bu¡er (10 mM HEPES/KOH pH 7.9, 10 mM
KCl, 1.5 mM MgCl2W6H2O, 0.5 mM PMSF, 1.5 mM 2-mercaptoeth-
anol) and incubated for 15 min on ice. The suspension was carefully
homogenized, followed by centrifugation (10 min, 1000Ug). The
supernatant was frozen at 320‡C, the pellet ( = nuclei) was resus-
pended in four pellet volumes of nuclear extraction bu¡er (20 mM
HEPES/KOH pH 7.9, 10% glycerol, 500 mM NaCl, 0.2 mM EDTA,
0.5 mM PMSF, 1.5 mM 2-mercaptoethanol) and incubated for 30 min
at 4‡C with agitation. After centrifugation (10 000Ug, 20 min), the
supernatant ( = nuclear extract) was used for further analysis.
2.5. SourceQ chromatography
Nuclear extracts dialyzed against column bu¡er (15 mM Tris^HCl,
pH 7.9, 10 mM NaCl, 0.25 mM EDTA, 1 mM 2-mercaptoethanol,
10% (v/v) glycerol) were loaded onto a 2 ml Source 30Q anion ex-
change column (Amersham Pharmacia Biotech, Uppsala, Sweden)
equilibrated with the same bu¡er. Elution of proteins was performed
with 60 ml of a linear gradient from 10 mM to 500 mM NaCl in
column bu¡er at a £ow rate of 1 ml/min. Fractions of 1.5 ml were
collected and assayed for HDAC activity. Aliquots of fractions with
HDAC activity were used for immunoblotting after precipitation of
protein using trichloro-acetic acid.
2.6. HDAC assay
HDAC activity was determined as described [39], using [3H]acetate-
prelabelled chicken erythrocyte histones as substrate. Sample aliquots
of 50 Wl were mixed with 10 Wl of total [3H]acetate-prelabelled chicken
reticulocyte histones (1 mg/ml). This mixture was incubated at 30‡C
for 1 h. The reaction was stopped by addition of 50 Wl of 1 M HCl/
0.4 M acetate and 800 Wl of ethylacetate. After centrifugation at
10 000Ug for 5 min, an aliquot of 600 Wl of the upper phase was
counted for radioactivity in 3 ml liquid scintillation cocktail. Nicotin-
amide adenine dinucleotide (NAD; Sigma, Vienna, Austria) was
added at a ¢nal concentration of 100 mM.
2.7. Immunoblot analysis
After electrophoresis of cellular or nuclear extracts on SDS^poly-
acrylamide gels, the proteins were transferred to PVDF membranes by
wet electroblotting in a bu¡er containing 25 mM Tris^HCl, 190 mM
glycine, 0.5% SDS, 10% methanol. Transfer was controlled by staining
the membrane with Ponceau S. Membranes were blocked by incuba-
tion in 5% non-fat dried milk in TBS-T (20 mM Tris^HCl pH 7.6,
137 mM NaCl, 0.1% Tween 20) for 1 h at room temperature. Incu-
bation with the primary antibody (rabbit polyclonal anti-HDAC-1,
anti-HDAC-2, and anti-HDAC-3, E. Seto, unpublished) was per-
formed for 60 min at room temperature, then the membranes were
washed twice with TBS-T and incubated with the secondary antibody
for 30 min. After four washes with TBS-T and one wash with TBS
(TBS-T without Tween 20), immunoreactive proteins were detected
using an enhanced chemiluminescence system (Amersham Life Sci-
ence, Braunschweig, Germany). The following antibodies were used:
anti-p16 (Pharmingen, Inc.), anti-cullin-1 (a gift from W. Krek, Basel,
Switzerland), anti-RbAp46/48 (Signal Transduction Laboratories).
2.8. Preparation of histones
Young (20 PDL) and senescent (56 PDL) ¢broblasts (equal number
of cells) were trypsinized from cell culture dishes and washed in a
bu¡er containing 10 mM Tris^HCl, 10 mM NaCl, and 5 mM MgCl2.
The cell pellet was resuspended in ¢ve pellet volumes of lysis bu¡er
(10 mM Tris^HCl, 10 mM NaCl, 5 mM MgCl2, 0.5% (v/v) Triton
X-100) and incubated for 1 h at 4‡C. Trichostatin A (100 ng/ml) was
added to prevent deacetylation of histones. After careful homogeni-
zation in a potter, lysis of the cells was controlled by microscopy.
After centrifugation (1000Ug, 10 min) the supernatant was stored
at 320‡C; the pellet was incubated with four pellet volumes of
0.5 M HCl overnight at 4‡C with agitation. The suspension was cen-
trifuged (8000Ug, 15 min) and the supernatant ( = S1) was mixed with
eight volumes of acetone and incubated overnight at 320‡C for pre-
cipitation. After centrifugation (15 000Ug, 4‡C, 15 min) the pellet was
vacuum-dried, then resuspended in 30 Wl H2O, followed by centrifu-
gation (15 000Ug, 10 min). The supernatant was removed and loaded
on a SDS^polyacrylamide gel (14%) and on an acid^urea^Triton
(AUT) gel (12%) [40] for analysis of the histones.
3. Results and discussion
Human diploid ¢broblasts were explanted from neonatal
foreskin and grown in culture until they reached the senescent
status. As was described by others before, the cells grew ex-
ponentially in early passages and reached a plateau after
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about 55 PDL (Fig. 1A). At this point, s 95% of the cells
were arrested in the G1 phase of the cell cycle and stained
positive for SA-L-galactosidase (data not shown), con¢rming
that all the cells were in the senescent state. Entering senes-
cence correlated with a downregulation of cyclin A gene ex-
pression (data not shown) and the upregulation of the
p16(INK4a) cdk inhibitor (Fig. 1B). Expression of cullin-1
[41], another nuclear protein assayed as control, was unaltered
during senescence (Fig. 1B).
To analyze histone acetylation, core histones were isolated
from young and senescent diploid human ¢broblasts. When
the histone acetylation status was analyzed by electrophoresis
on AUT gels [40], we found that histone H4 extracted from
diploid ¢broblasts shows a low degree of acetylation in that
basically the mono- and non-acetylated forms of H4 are
present. In these experiments, we detected no signi¢cant
change in the overall acetylation pattern when young and
senescent cells were compared (data not shown). To determine
if cellular senescence is accompanied by changes in the expres-
sion level of the known HDACs, we analyzed the expression
of HDACs 1, 2, and 3 during passaging of diploid human
¢broblasts. While we were unable to detect any speci¢c signal
with the HDAC-3 antibodies available to us (data not shown),
HDAC-1 and HDAC-2 were easily detected. Speci¢city of the
antibodies was con¢rmed in control experiments where
HDAC-1, -2, and -3 were transiently overexpressed in U2-
OS cells (data not shown). The level of HDAC-1 protein
decreased about 3-fold when cells reached the senescent state
(Fig. 2A), whereas the level of cullin-1 assayed as control was
not signi¢cantly altered. The decreased abundance of HDAC-
1 in senescent cells was correlated with a similar decrease in
the level of the corresponding mRNA (Fig. 2B), indicating
that with increasing passage number the expression of the
HDAC-1 gene is signi¢cantly reduced. We also noted a slight
reduction of HDAC-2 protein with increasing passage number
(Fig. 2A), which was however less pronounced than in the
case of HDAC-1; the HDAC-2 mRNA levels were not re-
duced in senescent cells (Fig. 2B).
We then analyzed the enzymatic activity of HDACs in ex-
tracts of young versus old cells. In these experiments we de-
tected slightly more (V1.5-fold) HDAC activity in nuclear
extracts of senescent cells than in extracts from young cells.
Since the protein levels for HDAC-1 and HDAC-2 are some-
what lower in senescent cells (Fig. 2A), this result suggests
that besides HDAC-1 and HDAC-2 other HDACs may be
present in senescent cells, which are not detected by the anti-
bodies available to us. To obtain further information on
changes in HDACs during replicative senescence, nuclear ex-
tracts from old and young cells were separated on an anion
exchange chromatography column where elution was per-
Fig. 1. Growth characteristics of human primary ¢broblasts. A: Hu-
man diploid ¢broblasts were isolated from neonatal foreskin and
grown in serial passage. A representative cumulative growth curve is
shown. B: The level of p16INK4a protein was determined in ex-
tracts from young (13 PDL) and senescent (55 PDL) ¢broblasts by
Western immunoblotting. Cullin-1 served as loading control.
Fig. 2. Analysis of the expression of HDAC-1 and HDAC-2. Pri-
mary human ¢broblasts were grown in cell culture until they
reached replicative senescence. A: Cellular extracts were prepared
after various numbers of PDL (as indicated) and samples corre-
sponding to equal cell numbers were separated by SDS^PAGE and
analyzed by Western blot, using antibodies to HDAC-1, HDAC-2,
and cullin-1, respectively. B: RNA was prepared after various num-
bers of PDL and analyzed by Northern blot with probes speci¢c for
HDAC-1 and HDAC-2, as indicated. For loading control, the mem-
branes were reprobed for glyceraldehyde-3-phosphate-dehydrogenase
(GAPDH). Expression levels were determined relative to GAPDH
by densitometric scanning; values are provided in %.
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Fig. 3. Analysis of HDACs by anion exchange chromatography. Nuclear extracts from young (V20 PDL) and old (V56 PDL) ¢broblasts
were prepared and fractionated by SourceQ anion exchange chromatography. A: Every second fraction was analyzed for HDAC activity.
B: The same fractions as in A were analyzed for HDAC-1, HDAC-2, and pRbAp46/48 protein levels by immunoblot analysis. C: The levels of
HDAC activity and of densitometrically scanned HDAC-1 and HDAC-2 protein are plotted; each signal was normalized to the respective level
found in fraction 19 from young cells.
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formed with a NaCl gradient, followed by measurement of
deacetylase activity in the eluted fractions. In these experi-
ments, we reproducibly observed the following chromato-
graphic patterns: in young cells, there was a major peak of
activity which eluted at 280 mM NaCl (fraction 19) from the
anion exchange column. There were also two minor peaks at
330 mM and 380 mM NaCl. When extracts from senescent
cells were analyzed the same way, two major peaks of activity
were present: the highest peak occurred in fraction 25, which
was eluted at 370 mM NaCl. We also observed a second peak
in fraction 19, which eluted at the same salt concentration
(280 mM) as the peak obtained in the young cells. The chro-
matogram shown in Fig. 3A has been independently observed
in two experiments which gave identical patterns. This ¢nding
indicates that both young and senescent cells contain similar
amounts of a common HDAC activity which can be eluted
from a SourceQ column at 280 mM NaCl. In addition to this
common type of enzyme, senescent cells contain an addition-
al, biochemically distinct HDAC activity, which is much less
abundant in young cells.
To investigate if HDAC-1 or HDAC-2 are associated with
any of the enzymatic activities shown in Fig. 3A, we probed
fractions obtained by the anion exchange chromatography
with antibodies to either HDAC-1 or HDAC-2 (Fig. 3B).
This experiment revealed that in young cells the major peak
of activity associated with a strong peak of HDAC-1 in frac-
tion 19. In senescent cells, the bulk of HDAC-1 also eluted at
280 mM NaCl and was also present in fraction 19. As in the
young cells, traces of HDAC-1 from senescent cells were also
present in the three consecutive fractions (21^25). When these
blots were probed with an antibody to HDAC-2, we found
that in extracts from young cells, the bulk of the HDAC-2
protein eluted as a sharp peak at 280 mM NaCl coeluting
with HDAC-1 in fraction 19. In chromatographic fractions
derived from senescent cells, on the other hand, HDAC-2
shows a much broader distribution. First, HDAC-2 clearly
eluted before HDAC-1, at a salt concentration of 240 mM
(fraction 17). Second, signi¢cant amounts of HDAC-2 were
present in six consecutive fractions from 17 to 27 (Fig. 3B). A
clear-cut peak for HDAC-2 is seen at 370 mM NaCl (fraction
25). This result suggests that in senescent cells HDAC-2 is
present in two major complexes of di¡erent chromatographic
behavior.
The relative expression level of HDAC-1 and HDAC-2 in
individual fractions was quanti¢ed by densitometric scanning
and plotted against the catalytic activity present in these frac-
tions. Comparing the relative activity and the relative protein
levels (Fig. 3C), we concluded that the activity peak eluting at
280 mM NaCl is most likely due to both HDAC-1 and
HDAC-2, which are both present in the respective fractions
derived from both old and young cells. While the chromato-
graphic behavior of HDAC-1 from young and senescent ¢-
broblasts is quite similar, a signi¢cant di¡erence was observed
for HDAC-2. In young cells, HDAC-2 is present in a single
peak, eluting at 280 mM NaCl. In senescent cells, on the other
hand, at least two additional peaks of HDAC-2 exist, eluting
at 240 mM and 370 mM, respectively.
In several mammalian cell types, HDAC-1 and HDAC-2
are tightly associated with each other in a ‘corepressor core
complex’ that invariably contains also two other closely re-
lated proteins, RbAp46 [27] and RbAp48 [28] (for review, see
[31]). Since in senescent cells HDAC-2 is found in fractions
devoid of HDAC-1, it appears that the association of both
proteins is partly abolished in senescent cells (Fig. 3B). To
better characterize the HDAC-containing fractions described
here, we also analyzed the distribution of RbAp46/48 in the
chromatographic fractions, using a polyclonal antiserum that
recognizes both RbAp46 and RbAp48. RbAp46/48 proteins
are expressed in young ¢broblasts and their abundance is not
signi¢cantly altered in senescent cells (data not shown). When
we probed the HDAC-2-containing fractions with antibodies
to RbAp46/48, we found that the RbAp proteins coelute with
both HDAC-1 and HDAC-2 in young cells. In senescent cells,
however, the senescent-speci¢c forms of HDAC-2 (namely in
fractions 17, 25, and 27) are devoid of RbAp46/48 (Fig. 3B).
This ¢nding indicates that an age-dependent remodelling of
HDAC-2-containing complexes occurs in human ¢broblasts.
As was also mentioned above, it is quite likely that not all
of the catalytic activity shown in Fig. 3A can be ascribed to
either HDAC-1 or HDAC-2. This raises the possibility that
some of the fractions contain unidenti¢ed HDAC(s), which
correspond neither to HDAC-1 nor HDAC-2. However, the
identity of such proteins remains to be determined. To address
this point, the fractions were also probed with antibodies to
HDAC-3, -4, -5, -6, -7, and -8; however, none of the anti-
bodies available to us revealed a speci¢c band in any of the
fractions (data not shown). Furthermore, the detection of
HDAC-1 or HDAC-2 protein in a fraction does not necessa-
rily mean that the protein contributes to the enzymatic activ-
ity that can be measured. Besides a potential modulation of
HDAC activity through associated proteins (see above), the
detectable enzymatic activity may also depend on the presence
of inhibitors and/or essential co-factors. While endogenous
inhibitors of HDACs are not known in mammalian cells, it
was reported recently that a HDAC from yeast, which plays a
role in age-dependent gene expression, depends on NAD as a
Fig. 4. In£uence of NAD on HDAC activity in chromatographic
fractions. Nuclear extracts from young (V20 PDL) and old (V56
PDL) ¢broblasts were prepared and fractionated by anion exchange
chromatography. Every second fraction was analyzed for histone
acetylase activity in the absence of exogenous NAD (8) or after
addition of 100 mM NAD (b).
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co-factor for activity. NAD-dependent deacetylases were also
described in other systems [42^44] (for review, see [45]). To
determine whether any of the activities detected in our cell
extracts may depend on NAD as a co-factor, chromato-
graphic fractions derived from young and old cells were re-
assayed for their enzymatic activity, after addition of 100 mM
NAD. This experiment revealed that the catalytic activity of
the enzyme(s) present in all fractions was not changed by the
addition of NAD (Fig. 4). From these data we conclude that
NAD is not a limiting factor for the HDAC activities that are
detectable in vitro when acetylated histones are used as sub-
strate and raises the question whether, by analogy to yeast
ageing, NAD-dependent HDACs play an important role for
age-dependent gene expression in human ¢broblasts.
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